| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711637 | Annals of Allergy, Asthma & Immunology | 2018 | 37 Pages |
Abstract
EAIs should be available in the community with doses and needle depths that meet the needs of all patients. More research on epinephrine pharmacodynamics are needed in children and adults in anaphylaxis, to better delineate what optimal doses should be. Optimizing epinephrine dose and delivery has the potential to improve anaphylaxis outcomes and prevent adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Julie C. MDCM, MPH,